trial

Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors

NCTId NCT00178932
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 37 (actual)
Sponsored by Northwestern University
Primary completion 2024-05-16
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
37 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
None
Start
1998-11
Primary completion
2024-05-16
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
genetic analysisgenetic assay

Sponsors

Northwestern UniversityLead Sponsor

Investigators

1
Herbert Y Meltzer, M.D.Principal Investigator

Sites

1 total
Nashville, United States

Facts & assertions

4 sourced
Enrollment
37
Phase
NA
Primary Completion Date
2024-05-16
Status
COMPLETED
relationships
The graph out of here
drug
genetic analysis
drug
genetic assay
drug
lead_sponsor
Northwestern University
company
indication
Bipolar Disorder
indication
Schizoaffective Disorder
indication
Depressive Disorder, Major
indication
investigator
Herbert Y Meltzer, M.D.
person